![[DEF 14A] ALX ONCOLOGY HOLDINGS INC Definitive Proxy Statement](https://www.sec.gov/Archives/edgar/data/0001810182/000119312526163936/img218488490_1.jpg)
Neutral
[DEF 14A] ALX ONCOLOGY HOLDINGS INC Definitive Proxy Statement
ALX Oncology Holdings Inc. (ALXO) has filed its definitive proxy statement (DEF 14A) for its 2026 annual stockholders' meeting, to be held virtually o...
ALXO
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (2)
Bearish (0)
Latest ALXO News
Neutral
Neutral
ALX Oncology (NASDAQ: ALXO) awards 800,000 options to chief officer
ALX Oncology Holdings Inc. (NASDAQ: ALXO) has granted its Chief Development & Operating Officer, Jeff E. Knight, 800,000 stock options with an exercis...
Research ALXO on:
Ad Space